MomMoodBooster Web-Based Intervention for Postpartum Depression: Feasibility Trial Results

MomMoodBooster Web-Based Intervention for Postpartum Depression: Feasibility Trial Results
复制标题

DOI:
10.2196/jmir.2876
复制
发表时间:
2013-11-01
影响因子:
7.4
通讯作者:
Lewinsohn, Peter
Lewinsohn, Peter
中科院分区:
医学2区
文献类型:
--
作者:
Danaher, Brian G.;Milgrom, Jeannette;Lewinsohn, Peter

文献摘要

被引文献

相似文献

背景:产后抑郁症(PPD)是分娩过程中最常见的并发症,是一种严重扰乱家庭互动并对妇女健康和婴儿健康发育造成严重持久影响的重大而普遍的公共卫生问题。如果不进行治疗,这些后果的严重性会增加;大多数产后抑郁妇女由于一系列后勤和态度障碍而得不到帮助。目的:这项试点研究旨在测试基于网络的创新和互动指导的产后抑郁症干预措施(MMB)的可行性、可接受性和潜在有效性。方法:邀请符合资格标准的53名妇女(=18岁、家庭互联网接入和使用个人电子邮件、爱丁堡产后抑郁调查评分12-20或患者健康问卷评分10-19)使用MMB计划。评估是在筛查/前测、后测(注册后3个月)和6个月随访时进行的。结果:所有6个课程的参与者都完成了87%(46/53)的课程。参与者参与了该计划:访问天数(平均15.2,SD 8.7)、访问次数(平均20.1,SD 12.2)、以小时为单位的总访问持续时间(平均5.1,SD 1.3)和6个会话中的观看次数(平均5.6,SD 1.3)都支持高使用率。后测数据来自89%的参与者(47/53),6个月的随访数据来自87%的参与者(46/53)。在预测试中,55%(29/53)的参与者符合PHQ-9的轻度或重度抑郁症标准。在后测试中,90%(26/29)不再符合标准。结论:这些发现支持MMB计划的扩大使用和额外测试,包括在一系列临床和公共卫生环境中的实施。
Background: Postpartum depression (PPD)-the most common complication of childbirth-is a significant and prevalent public health problem that severely disrupts family interactions and can result in serious lasting consequences to the health of women and the healthy development of infants. These consequences increase in severity when left untreated; most women with PPD do not obtain help due to a range of logistical and attitudinal barriers.Objective: This pilot study was designed to test the feasibility, acceptability, and potential efficacy of an innovative and interactive guided Web-based intervention for postpartum depression, MomMoodBooster (MMB).Methods: A sample of 53 women who satisfied eligibility criteria (= 18 years of age, home Internet access and use of personal email, Edinburgh Postnatal Depression Survey score of 12-20 or Patient Health Questionnaire score from 10-19) were invited to use the MMB program. Assessments occurred at screening/pretest, posttest (3 months following enrollment), and at 6 months follow-up.Results: All six sessions of the program were completed by 87% (46/53) of participants. Participants were engaged with the program: visit days (mean 15.2, SD 8.7), number of visits (mean 20.1, SD 12.2), total duration of visits in hours (mean 5.1, SD 1.3), and number of sessions viewed out of six (mean 5.6, SD 1.3) all support high usage. Posttest data were collected from 89% of participants (47/53) and 6-month follow-up data were collected from 87% of participants (46/53). At pretest, 55% (29/53) of participants met PHQ-9 criteria for minor or major depression. At posttest, 90% (26/29) no longer met criteria.Conclusions: These findings support the expanded use and additional testing of the MMB program, including its implementation in a range of clinical and public health settings.